Ovarian Cancer
The firm has commercialized its pancreatic cancer test and has its sights set on an ovarian cancer test launching in 2023.
Functional Precision Medicine Firm Kiyatec Raises $18M in Series C Funding Round
The Clemson University spinout is developing live tissue-based models of cancer cells for use in predicting patients' individual drug responses.
Intermountain Builds Up Bioinformatics to Make HerediGene Sequencing Data Clinically Actionable
Premium
The health system, which has now enrolled 150,000 people in its population genomics program, has implemented its technology across CDC tier one conditions but has grander ambitions.
Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer
Researchers examined genetic, tumor mutation, and immune features among individuals surviving at least a decade after an advanced ovarian cancer diagnosis.
Results from a homologous recombination deficiency assay concordance study led by Friends of Cancer Research were presented at the AMP annual meeting.